Oncología Hepática
![Foto de Oncología Hepática](/img/uploaded/9779007d9f465a3a4fb0cd4fb6a82d66.jpg)
![Foto de University of Michigan Medical School](/img/noimage_org.png)
University of Michigan Medical School
Ann Arbor, Estados UnidosPublicaciones en colaboración con investigadores/as de University of Michigan Medical School (1)
2017
-
Nivolumab in patients with advanced hepatocellular carcinoma (CheckMate 040): an open-label, non-comparative, phase 1/2 dose escalation and expansion trial
The Lancet, Vol. 389, Núm. 10088, pp. 2492-2502